 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
||||||||||||||||||||
|
 Arbor Vita is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs and diagnostics addressing disease through a new family of targets, PDZ proteins. PDZ proteins are critical elements that organize and regulate many signaling pathways in human cells. The disruption of PDZ interactions has recently begun to be appreciated as providing a novel way to control multiple signaling cascades in complex diseases. Arbor Vita is pioneering the development of therapeutics and diagnostics through their unique understanding of the role of PDZs in cell signaling and disease. The company is tackling major health issues including cancer; infectious diseases such as influenza; stroke and cardiovascular disease. |
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|